Integrated DNA Technologies began production in San Diego to serve West Coast customers
On Dec. 15, 2005, Integrated DNA Technologies (IDT) announced the completion of its acquisition of San Diego, CA…
Biotechnology | Diagnostics | Disease | Life Science News | Oncology | Therapeutics | Women's Health
Studies validated a new test can predict risk of breast cancer recurrence in a sizable group of patients
On Dec. 7, 2005, results from several studies presented at the San Antonio Breast Cancer Symposium validated that…
Biotechnology | Diagnostics | Life Science News | Non-Profit Research | Oncology | Radiology | Therapeutics
Karmanos Cancer Institute became Michigan’s first and only independent hospital exclusively for cancer patients
On Dec. 1, 2005, the Barbara Ann Karmanos Cancer Institute became Michigan’s first and only independent hospital exclusively…
Biotechnology | Diagnostics | Life Science News | NIH | Non-Profit Research | Oncology | Therapeutics | U.S. Congress | Women's Health
The 2-Year Extension of Postage Stamp for Breast Cancer Research (PL 109-100) was extended
On Nov. 11, 2005, the U.S. Congress authorized the 2-year extension of Postage Stamp for Breast Cancer Research…
Stanford researchers discovered obestatin, a hormone that suppresses appetite
On Nov. 10, 2005, Stanford researchers announced they had discovered obestatin, a hormone that suppresses appetite. The discovery…
National Cancer Institute launched a cancer biorepository pilot project to standardize biospecimen collection
On Nov. 7, 2005, the National Cancer Institute launched a cancer biorepository pilot project designed to standardize biospecimen…
Biotechnology | Infectious Disease | Life Science News | Non-Profit Research | Therapeutics | Vaccine
The Bill & Melinda Gates Foundation announced grants totaling $258 million to develop a malaria vaccine
On Oct. 30, 2005, the Bill & Melinda Gates Foundation announced three grants totaling $258.3 million for advanced…
Arizona BioIndustry Association secured three-year Flinn Foundation grant to support educational outreach
On Oct. 18, 2005, the Arizona BioIndustry Association (AZBio) announced a three-year grant from the Flinn Foundation to…
Federal Medicare rule required all long-term care facilities to offer vaccination for influenza and pneumococcal disease
On Oct. 7, 2005, a new Federal Medicare rule became effective that required all long-term care facilities to…
The genome of the 1918 H1N1 pandemic influenza virus was sequenced
On Oct. 7, 2005, Jeffery Taubenberger, AH Reid, AE Krafft, Karen Bijwaard and Thomas Fanning published a report…
Biotechnology | Diagnostics | Disease | Life Science News | NIH | Non-Profit Research | Oncology | Therapeutics
Annual Report to the Nation on the Status of Cancer showed cancer death rates dropped from 1993-2002
On Oct. 5, 2005, the National Cancer Institute’s Annual Report to the Nation on the Status of Cancer,…
Biotechnology | Diagnostics | Disease | Life Science News | Non-Profit Research | Oncology | Radiology | Therapeutics
Siteman Cancer Center opened a new center at Barnes-Jewish St Peters Hospital
On Sept. 22, 2005, the Siteman Cancer Center opened a new center at Barnes-Jewish St. Peters Hospital. The…
Preliminary results from clinical trial of digital vs. film mammography showed no difference in breast cancer detection
On Sept. 16, 2005, preliminary results from a large, clinical trial of digital vs. film mammography showed no…
Biotechnology | Diagnostics | Genomics | Life Science News | Medicine | Non-Profit Research | Therapeutics
David H Murdock announced a $1.5 billion North Carolina Research Campus
On Sept. 12, 2005, David H. Murdock announced a $1.5 billion scientific and economic revitalization project called the…
A vaccine that combined the measles, mumps, rubella, and varicella antigens was licensed
On Sept. 6, 2005, the vaccine that combined the measles, mumps, rubella, and varicella antigens (Proquad by Merck)…
An inactivated, injectable influenza vaccine was licensed
On Aug. 31, 2005, the inactivated, injectable influenza vaccine (Fluarix) by GlaxoSmithKline (GSK) was licensed. The vaccine was…
The CDC responded to the crises presented by Hurricanes Katrina and Rita
On Aug. 29, 2005, the U.S. Centers for Disease Control and Prevention (CDC) responded to the crises presented…
FDA approved lowering the age limit to 12 mos for one of the two licensed hepatitis A vaccine
On Aug. 11, 2005, the Food and Drug Administration (FDA) approved an application of a pediatric/adolescent formulation of…
The Energy Policy Act was signed into law, authorizing incentives for bioethanol development
On Aug. 8, 2005, the Energy Policy Act ( P.L. 109-58 ) was passed by the U.S. Congress…
The National Cancer Institute approved a $10 million award for OHSU Cancer Institute
On Jul. 18, 2005, Oregon Health & Science University (OHSU) announced receipt of a five-year, $10 million award…
Life Sciences Discovery Fund Authority was created to help finance groundbreaking R&D
On Jul. 13, 2005, The Life Sciences Discovery Fund Authority (LSDF) was established and a total of $350…
Corixa Corp. was acquired by Glaxosmithkline for $300 million
On Jul. 12, 2005, Corixa Corp., based on First Hill in Seattle, was acquired by Glaxosmithkline (GSK) for…
Biotechnology | Disease | NIH | Therapeutics
The Patient Navigator Outreach and Chronic Disease Prevention Act amended the Public Health Service Act
On Jun. 29, 2005, the Patient Navigator Outreach and Chronic Disease Prevention Act of 2005 (P.L. 109-18) amended…
Amgen was awarded the E. Donnall Thomas Medal of Achievement Medal
On Jun. 22, 2005, the Fred Hutchinson Business Alliance announced that the 2005 E. Donnall Thomas Medal of…
FDA licensed a 2nd Tdap vaccine (Adacel by Sanofi Pasteur) for use in persons ages 11-64 years
On Jun. 9, 2005, the U.S. Food and Drug Administration (FDA) licensed a 2nd Tdap vaccine (Adacel by…
Andras Nagy announced Canada’s first human embryonic stem cell lines
On Jun 8, 2005, Dr. Andras Nagy at Mount Sinai Hospital announced Canada’s first human embryonic stem cell…
OMRF’s Sir Alexander Fleming scholar program celebrated it’s 50th class
On Jun. 8, 2005, the Oklahoma Medical Research Foundation’s Sir Alexander Fleming scholar program celebrated it’s 50th class…
Biotechnology | Diagnostics | Disease | Life Science News | Non-Profit Research | Oncology | Radiology | Therapeutics
Karmanos Cancer Institute acquired clinical facilities from the Detroit Medical Center
On May 1, 2005, The Wayne State University Karmanos Cancer Institute announced it had acquired its clinical facilities…
Biotechnology | Diagnostics | Disease | Life Science News | Oncology | Therapeutics | Women's Health
NCI-sponsored clinical trials showed patients with early-stage, HER2-positive, invasive breast cancer experienced decrease in risk of cancer recurrence
On Apr. 27, 2005, results from two large National Cancer Institute sponsored randomized clinical trials showed that patients…
NCI trial reported targeted agent trastuzumab and standard chemo cut risk of HER-2-positive breast cancer
On Apr. 25, 2005, the combination of the targeted agent trastuzumab (Herceptin) and standard chemotherapy cuts the risk…